This report was first published by Endpoints News. To see the original version, click here
Rick Pazdur, the head of the FDA’s drug office, is expected to leave the agency less than a month after stepping into the role.
His exit comes after he was personally lobbied by Commissioner Marty Makary to take the job, and was given assurances that he would be shielded from some of the chaotic dynamics that have affected other parts of the FDA, according to previous reporting by Endpoints News.
您已閱讀14%（488字），剩余86%（2958字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。